Riskpilot← Back to searchSign inGet full accessDINGO MEDICA AS
ASActiveOrg 919480866Stenkjørerbakken 26, 1684 VesterøyMedical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
NOK 4,3M
0% vs 2023
EBITDA margin
9.8%
-58% vs 2023
Equity ratio
32.1%
Financial strength
Net profit 2024
NOK 301K
-59% vs 2023
| Revenue | NOK 4,3M | +0% |
| EBITDA | NOK 424K | -58% |
| Net profit | NOK 301K | -59% |
| Total assets | NOK 1,6M | -28% |
| Equity | NOK 517K | -38% |
| Employees | 1 | — |
Legal name
DINGO MEDICA AS
Org number
919480866
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. august 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Medisinsk konsultasjons virksomhet, helsearbeid innen kirurgi av ortopediske problemstillinger, foredrag innen medisin, og å engasjere seg i beslektede virksomheter, samt alt hva som hermed måtte stå i forbindelse.
Address
Stenkjørerbakken 26, 1684 Vesterøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 234 | 4 271 | 4 171 | 4 297 | 4 307 |
| Staff expenses | −908 | −1 056 | −1 175 | −1 366 | −1 903 |
| EBITDA | 1 491 | 1 552 | 1 219 | 1 009 | 424 |
| Depreciation & amort. | −39 | −46 | −58 | −64 | −36 |
| EBIT | 1 452 | 1 506 | 1 160 | 946 | 388 |
| Net financials | −1 | 0 | 0 | 0 | 1 |
| Profit before tax | 1 451 | 1 506 | 1 160 | 946 | 389 |
| Tax | 320 | 335 | 258 | 212 | 88 |
| Net profit | 1 131 | 1 171 | 902 | 734 | 301 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 439 | 3 495 | 3 371 | 2 228 | 1 612 |
| Equity | 1 822 | 1 906 | 841 | 840 | 517 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 617 | 1 589 | 2 530 | 1 388 | 1 095 |
| Total debt | 617 | 1 589 | 2 530 | 1 388 | 1 095 |
EBITDA margin
9.8%
This company
15.8%
Market median
-38% vs market
20202024
Equity ratio
32.1%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
58.2%
This company
18.4%
Market median
+216% vs market
20202024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20202024
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20202024
Debt / equity
2.12×
This company
0.62×
Market median
-242% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2017 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dingo As
DINGO MEDICA AS Board members of DINGO MEDICA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Henry Sundøen | Chief Executive Officer | 0 companies |